Objective: To understand the status of treatment and assistance for advanced schistosomiasis patients in Changshu City from 2006 to 2014.

Methods: According to The Parasitic Disease Prevention Information Management System, the data of treatment and assistance for advanced schistosomiasis patients were collected and analyzed statistically in Changshu City from 2006 to 2014.

Results: A total of 269 advanced schistosomiasis patients were assisted. The sex ratio of men: women was 0.56: 1 with an average age of 71.71 years. The ascites-type patients accounted for 78.25%, splenomegaly-type 21.20%, and colon proliferation-type 0.55%. The clinical cure rate was 12.29%, improvement rate 62.81%, and no-change 8.67%, and the total effective rate was 75.10%.

Conclusion: The treatment and assistance for advanced schistosomiasis patients has achieved the basic target of improving the symptoms, relieving pains and improving the living quality.

Download full-text PDF

Source

Publication Analysis

Top Keywords

advanced schistosomiasis
20
schistosomiasis patients
20
assistance advanced
16
changshu city
12
city 2006
12
treatment assistance
12
patients changshu
8
patients
6
advanced
5
schistosomiasis
5

Similar Publications

Introduction: Schistosomiasis (Bilharzia), a neglected tropical disease caused by parasites, afflicts over 240 million people globally, disproportionately impacting Sub-Saharan Africa. Current diagnostic tests, despite their utility, suffer from limitations like low sensitivity. Polymerase chain reaction (PCR) and quantitative real-time PCR (qPCR) remain the most common and sensitive nucleic acid amplification tests.

View Article and Find Full Text PDF

Hepato-intestinal schistosomiasis is characterized by severe pathological changes at advanced chronic stages, including granulomatous lesions and liver fibrosis. The objective of our research was to assess the dynamic expression of profibrotic molecules, the transforming growth factor beta 1 (TGF-β1), and proinflammatory cytokines immunomodulation induced by interleukin 17 (IL-17) neutralization in murine Schistosomiasis mansoni. The study included 56 specific pathogen-free male C57BL/6 mice, divided into 3 main groups: GI uninfected normal controls, GII S.

View Article and Find Full Text PDF

For over three decades, praziquantel (PZQ) has been the mainstay chemotherapy for prevention and treatment of schistosomiasis. The excessive use of PZQ, coupled with the lack of advanced drug candidates in the current anti-schistosomiasis drug development pipeline, emphasizes the genuine need for new drugs. In the current work, we investigated the antischistosomal potential of a new series of compounds derived from the privileged benzimidazole scaffold, which exhibited low micromolar IC potency in the range of 1.

View Article and Find Full Text PDF

The occurrence of hepatitis E virus (HEV) in patients with Schistosomiasis mansoni (SM) is still poorly understood in Brazil. The objective of this study was to estimate the seroprevalence of anti-HEV IgG in patients with SM and its association with the periportal fibrosis (PPF), assessed by serum markers and ultrasound criteria. This cross-sectional study was carried out in an endemic area in Pernambuco, Brazil, with schistosomal patients who underwent coproscopic survey.

View Article and Find Full Text PDF

In recent decades, technological advancements and scientific progress have significantly improved disease control strategies. However, the exclusive focus on these aspects often overlooks the crucial role of social and cultural factors. Local narratives, reflecting community traditions and beliefs, offer valuable insights that can influence the success of public health interventions.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!